VolitionRx

Henderson, United States

VolitionRx develops easy to use blood-based cancer tests to accurately diagnose a range of cancers.

$4.6M raised

Jun 2026

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has VolitionRx raised?

VolitionRx has raised $4.6M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.

Who are VolitionRx's investors?

VolitionRx's investors include WE International, Namur Invest.

Where is VolitionRx headquartered?

VolitionRx is headquartered in Henderson, United States.

What does VolitionRx do?

VolitionRx develops easy to use blood-based cancer tests to accurately diagnose a range of cancers.

What stage is VolitionRx at?

VolitionRx is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 7, 2026.

MLA

"VolitionRx — Funding & Investors." VCBacked, June 7, 2026, https://www.vcbacked.co/company/volitionrx. Accessed July 3, 2026.

APA

VCBacked. (2026). VolitionRx — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/volitionrx

Wikipedia (cite web)

{{cite web |title=VolitionRx — Funding & Investors |url=https://www.vcbacked.co/company/volitionrx |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 7, 2026.